To further assess the impact of FTO expression in clinical cases of ccRCC, we next analysed RNA sequencing data from over 500 patients with ccRCC from the Cancer Genome Atlas (TCGA). The gene discussed is FTO; the disease is nonpapillary renal cell carcinoma.